QBiotics has recently added the novel compound WH1 to our product development pipeline. WH1 is proving to have promising potential as a wound healing agent.
Anecdotal evidence gained from ‘real world’ case studies treating dogs in the veterinary environment supports the ability of WH1 to stimulate rapid wound closure, reduce or eliminate infection and result in good cosmetic outcomes in the form of low rate of scarring.
In vitro studies have demonstrated the ability of WH1 to:
- selectively stimulate the migration of ‘wound healing’ cells in the wound as compared to cells that result in increased scarring, and
- stimulated the presence of signaling molecules involved in wound repair and healing in cells.